More Business Wire
View Older Stories View Newer Stories-
Cofactor Genomics expands clinical use of OncoPrism, as their AI enabled RNA test achieves national clinical validation after predicting immunotherapy response in Lung Cancer Patients
-
The Standard Hires Ashleigh Tucci as National Accounts Sales Manager
-
RGA Launches Aspire, a Cutting-Edge Health Insurance Administration Platform in UAE
-
The Veterinary Cooperative (TVC) and Wedgewood’s Blue Rabbit Platform Announce New Partnership to Offer Best-in-Class Veterinary Home Delivery Services
-
Fluor-led Joint Venture Receives Limited Notice to Proceed for Expansion of Nuclear Power Plant in Romania
-
Port Houston Fiscal Year 2025 Budget Approved
-
KBRA Releases Research – 2025 RMBS Sector Outlook: Growth on the Horizon
-
NYLI MacKay DefinedTerm Muni Opportunities Fund Announces Preliminary Results of Tender Offer
-
The AZEK Company Named as Chicago Tribune Top Workplace for Fourth Consecutive Year
-
Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2024 Results
-
Jamieson Wellness Inc. Appoints New Board Director
-
Cinemark to Participate in Wells Fargo Institutional Investor Conference
-
AstroNova to Report Third-Quarter Fiscal 2025 Financial Results on Thursday, December 12
-
Cantaloupe, Inc. Honored with Two Prestigious Technology Association of Georgia Awards for Innovation and Impact in Fintech
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatc
-
Answer ALS Releases World's Largest ALS Patient-Based iPSC and Bio Data Repository
-
WiSA Technologies, Inc. Reports Q3 2024 Results
-
The Future of Diffuse Large B-Cell Lymphoma (DLBCL) Treatment: Insights from Global Research
-
VSee Health Reports Third Quarter 2024 Revenue Up 131% Year-over-Year
-
KB Home Announces the Grand Opening of Its Newest Community in a Prime Elk Grove, California Location
-
Soluna Holdings Reports Q3’24 Results
-
Intrepid Fiber Groundbreaking in Broomfield, CO
-
Murchinson Refutes Nano Dimension’s Latest False and Misleading Claims
-
Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
-
Certain Closed-end Funds Advised by Franklin Templeton Fund Adviser, LLC Announce Appointment of New Chair and Directors
-
Synthekine to Present Preclinical Data for CD19 CAR-T (SYNCAR-001) Empowered by Orthogonal IL-2 (STK-009) Without Lymphodepletion at American College of Rheumatology (ACR) Convergence 2024
-
Existing Home Sales Post Biggest Increase in Nearly Three Years
-
Telered and Discover® Global Network Sign Strategic Alliance, Increasing Acceptance for Cardholders
-
Clarion Partners Real Estate Income Fund Inc. (CPREX) Announces Tender Offer
-
Wells Fargo & Company Declares Cash Dividends on Preferred Stock
-
Teledyne’s New Generation Onboard Secure Data Loader eADL XS™ Certified on Boeing 737NG Aircraft
-
Slate Grocery REIT Announces Distribution for the Month of November 2024
-
Sprinklr Announces Date of Third Quarter Financial Results
-
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases
-
McAfee’s 2024 Global Holiday Shopping Scams Study Highlights Growing Concerns Over AI-Powered Scams, Including Deepfakes, Impacting Holiday Shoppers
-
Altius Renewable Royalties Reports Positive Recommendations from ISS and Glass Lewis to vote FOR the Arrangement Resolution
-
Laser Photonics Corporation Welcomes New Executive Vice President
-
Albany International Corp. Announces Plans to Consolidate Manufacturing Capacity
-
Ellington Financial Inc. Completes Non-QM Securitization
-
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Non-Epithelioid Malignant Pleural Mesothelioma (MP
-
NMG Provides Update on its Progress Toward FID for its Fully Integrated Ore-to-Active-Anode-Materials Phase-2 Operations
-
Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B
-
Marret Asset Management Inc. Reiterates Termination of Marret High Yield Strategies Fund and Marret Multi-Strategy Income Fund
-
Harrow Announces Participation in Upcoming Investor Conferences
-
Exchange Income Corporation Announces November 2024 Dividend
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Repotrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer and Advanced NTRK-Positive Solid Tumors
-
Palantir Launches AIP for Developers at DevCon
-
Kontrol Technologies Wins Multiple City Customers for Building Decarbonization; Accelerates Bitcoin on the Balance Sheet Strategy
-
Equity Commonwealth Declares Initial Cash Liquidating Distribution of $19.00 Per Common Share and Announces Ex-Dividend Date
-
Alibaba Group Announces September Quarter 2024 Results

